Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

AbbVie Inc (ABBV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AbbVie's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
157.07 -1.19    -0.75%
24/05 - Closed. Currency in USD ( Disclaimer )
After Hours
157.29
+0.22
+0.14%
0:56:43 - Real-time Data
  • Volume: 3,187,340
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 156.36 - 158.83
Type:  Equity
Market:  United States
AbbVie 157.07 -1.19 -0.75%

NYSE:ABBV Financials

 
This summary provides an overview of the most significant critical numbers from each of the AbbVie financial reports, including theAbbVie Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NYSE:ABBV financials over time via breakdowns of their annual reports.

AbbVie Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 14,301 million compared to USD 15,121 million a year ago. Net income was USD 822 million compared to USD 2,473 million a year ago. Diluted earnings per share from continuing operations was USD 0.46 compared to USD 1.38 a year ago.For the full year, sales was USD 54,318 million compared to USD 58,054 million a year ago. Net income was USD 4,863 million compared to USD 11,836 million a year ago. Diluted earnings per share from continuing operations was USD 2.72 compared to USD 6.63 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ABBV Income Statement & Profits

Gross margin TTM 69.17%
Operating margin TTM 32.11%
Net Profit margin TTM 11.02%
Return on Investment TTM 19.22%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 12310 14301 13927 13865
Gross Profit 8294 10026 7462 9657
Operating Income 3483 4549 2473 4772
Net Income 1369 822 1778 2024

ABBV Balance Sheet

Quick Ratio MRQ 0.72
Current Ratio MRQ 0.94
LT Debt to Equity MRQ 801.32%
Total Debt to Equity MRQ 928.67%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 148874 134711 136221 135367
Total Liabilities 140827 124314 124092 122469
Total Equity 8047 10397 12129 13303

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 12.81
Revenue/Share TTM 30.72
Operating Cash Flow  9.73%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 4040 4753 7574 6319
Cash From Investing Activities -9588 -800 -369 -341
Cash From Financing Activities 10819 -4449 -2661 -3920
Net Change in Cash 5253 -473 4528 2048
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABBV Price Commentary

Write your thoughts about AbbVie Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alan Ng
Alan Ng Oct 07, 2021 15:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Abbv going up again.
tyler dong
tyler dong Sep 01, 2021 16:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is happening to abbvie?
Matous B
Matous B Sep 01, 2021 16:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ABBV : FDA requires updated warnings on JAK inhibitors citing increased risks of heart events10:56 am, Wed, Sep. 1, 2021
Oc Masai
Oc Masai Jul 12, 2021 18:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bullish guys
Thusara Dissanayake
Thusara Dissanayake Jan 30, 2016 18:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi how will be EUR/USD next week
James Macdonald
James Macdonald Jan 30, 2016 18:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cloudy with a chance of rain
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email